Critical role of dendritic cells in mouse mammary tumor virus in vivo infection

Journal of Virology

Volumn 81, Issue 8, 2007, Pages 3769-3777

  Courreges, Maria Cecilia ^a   Burzyn, Dalia ^b   Nepomnaschy, Irene ^b   Piazzon, Isabel ^b   Ross, Susan R ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b INST DE INVEST HEMATOLOGICAS   (Argentina)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOPATHOGENESIS; IN VIVO STUDY; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ANIMALS; CELL MOVEMENT; DENDRITIC CELLS; LYMPH NODES; MACROPHAGE INFLAMMATORY PROTEINS; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, TRANSGENIC; RETROVIRIDAE INFECTIONS; TUMOR VIRUS INFECTIONS;

BETARETROVIRUS; MOUSE MAMMARY TUMOR VIRUS; MUS;

EID: 34247137541     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02728-06     Document Type: Article

References (44)

1. Ardavin, C., I. Ferrero, I. Azcoitia, F. Anjuere, H. Diggelman, F. Luthi, S. Luther, and H. Acha-Orbea. 1999. B cell response after MMTV infection: extrafollicular plasmablasts represent the main infected population and can transmit viral infection, J. Immunol. 162:2538-2545.
2. Ardavin, C., F. Luthi, M. Andersson, L. Scarpellino, P. Martin, H. Diggelmann, and H. Acha-Orbea. 1997. Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model. J. Virol. 71:7295-7299.
3. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.-J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
4. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
5. Baribaud, F., I. Maillard, S. Vacheron, T. Brocker, H. Diggelmann, and H. Acha-Orbea. 1999. Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen. J. Virol. 73:8403-8410.
6. Barton, G. M., and R. Medzhitov. 2002. Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14:380-383.
7. Beutner, U., E. Draus, D. Kitamura, K. Rajewsky, and B. T. Huber. 1994. B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J. Exp. Med. 179:1457- 1466.
8. Burzyn, D., J. C. Rassa, D. Kim, I. Nepomnaschy, S. R. Ross, and I. Piazzon. 2004. Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J. Virol. 78:576-584.
9. Cassell, D. J., and R. H. Schwartz. 1994. A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation. J. Exp. Med. 180:1829-1840.
10. Chesnut, R. W., and H. M. Grey. 1981. Studies on the capacity of B cells to serve as antigen-presenting cells. J. Immunol. 126:1075-1079.
11. Czarneski, J., P. Berguer, P. Bechinschtein, I. Nepomnaschy, I. Piazzon, N. Wagner, and S. R. Ross. 2002. Neonatal infection with mouse mammary tumor virus is not dependent on b7 integrin- or L-selectin-expressing lymphocytes. Eur. J. Immunol. 32:945-956.
12. de Witte, L., M. Abt, S. Schneider-Schaulies, Y. van Kooyk, and T. B. Geijtenbeek. 2006. Measles virus targets DC-SIGN to enhance dendritic cell infection. J. Virol. 80:3477-3486.
13. Dzuris, J. L., T. V. Golovkina, and S. R. Ross. 1997. Both T and B cells shed infectious MMTV. J. Virol. 71:6044-6048.
14. Golovkina, T., M. Schlomchik, L. Hannum, and A. Chervonsky. 1999. Organogenic role of B lymphocytes in mucosal immunity. Science 286:1965-1968.
15. Golovkina, T. V., A. Chervonsky, J. A. Prescott, C. A. Janeway, and S. R. Ross. 1994. The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells. J. Exp. Med. 179:439-446.
16. Golovkina, T. V., J. P. Dudley, A. Jaffe, and S. R. Ross. 1995. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection. Proc. Natl. Acad. Sci. USA 92:4828-4832.
17. Golovkina, T. V., J. L. Dzuris, B. van den Hoogen, A. B. Jaffe, P. C. Wright, S. M. Cofer, and S. R. Ross. 1998. A novel membrane protein is a mouse mammary tumor virus receptor. J. Virol. 72:3066-3071.
18. Golovkina, T. V., A. B. Jaffe, and S. R. Ross. 1994. Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range. J. Virol. 68:5019-5026.
19. Golovkina, T. V., I. Piazzon, I. Nepomnaschy, V. Buggiano, M. de Olano Vela, and S. R. Ross. 1997. Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses. J. Virol. 71:3895-3903.
20. Held, W., G. A. Waanders, H. Acha-Orbea, and H. R. MacDonald. 1994. Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: implications for superantigen function. J. Exp. Med. 180:2347-2351.
21. Jude, B. A., Y. Pobezinskaya, J. Bishop, S. Parke, R. M. Medzhitov, A. V. Chervonsky, and T. V. Golovkina. 2003. Subversion of the innate immune system by a retrovirus. Nat. Immunol. 4:573-578.
22. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, E. G. Pamer, D. R. Liftman, and R. A. Lang. 2003. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17:211-220.
23. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77-92.
24. Martin, P., S. R. Ruiz, G. Martinez del Hoyo, F. Anjuere, H. H. Vargas, M. Lopez-Bravo, and C. Ardavin. 2002. Dramatic increase in lymph node dendritic cell numbers during infection by the mouse mammary tumor virus occurs by a CD62L-dependent blood-borne DC recruitment. Blood 99:1282-1288.
25. Nandi, S., and C. M. McGrath. 1973. Mammary neoplasia in mice. Adv. Cancer Res. 17:353-414.
26. Niess, J. H., and H. C. Reinecker. 2006. Dendritic cells in the recognition of intestinal microbiota. Cell. Microbiol. 8:558-564.
27. Pear, W. S., J. P. Miller, L. Xu, J. C. Pui, B. Soffer, R. C. Quackenbush, A. M. Pendergast, R. Bronson, J. C. Aster, M. L. Scott, and D. Baltimore. 1998. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92:3780-3792.
28. Pollara, G., A. Kwan, P. J. Newton, M. E. Handley, B. M. Chain, and D. R. Katz. 2005. Dendritic cells in viral pathogenesis: protective or defective? Int. J. Exp. Pathol. 86:187-204.
29. Rassa, J. C., J. L. Meyers, Y. Zhang, R. Kudaravalli, and S. R. Ross. 2002. Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 99:2281-2286.
30. Rinaldo, C. R., Jr., and P. Piazza. 2004. Virus infection of dendritic cells: portal for host invasion and host defense. Trends Microbiol. 12:337-345.
31. Ross, S. R. 2000. Using genetics to probe host-virus interactions: the mouse mammary tumor virus model. Microbes Infect. 2:1215-1223.
32. Ross, S. R., J. J. Schofield, C. J. Farr, and M. Bucan. 2002. Mouse transferrin receptor 1 is the cell entry receptor for mouse mammary tumor virus. Proc. Natl. Acad. Sci. USA 99:12386-12390.
33. Sallusto, F., P. Schaerli, P. Loetscher, C. Schaniel, D. Lenig, C. R. Mackay, S. Qin, and A. Lanzavecchia. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28:2760-2769.
34. Shackleford, G. M., and H. E. Varmus. 1988. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc. Natl. Acad. Sci. USA 85:9655-9659.
35. Sozzani, S., P. Allavena, G. D'Amico, W. Luini, G. Bianchi, M. Kataura, T. Imai, O. Oshie, R, Bonecchi, and A. A. Mantovani. 1998. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161:1083-1086.
36. Sprecher, E., and Y. Becker. 1989. Langerhans cell density and activity in mouse skin and lymph nodes affect herpes simplex type 1 (HSV-1) pathogenicity. Arch. Virol. 107:191-205.
37. Steinman, R. M., A. Granelli-Piperno, M. Pope, C. Trumpfheller, R. Ignatius, G. Arrode, P. Racz, and K. Tenner-Racz. 2003. The interaction of immunodeficiency viruses with dendritic cells. Curr. Top. Microbiol. Immunol. 276:1-30.
38. Vacheron, S., S. J. Luther, and H. Acha-Orbea. 2002. Preferential infection of immature dendritic cells and B cells by mouse mammary tumor virus. J. Immunol. 168:3470-3476.
39. Vacheron, S., T. Renne, and H. Acha-Orbea. 1997. A highly sensitive in vitro infection assay to explore early stages of mouse mammary tumor virus infection. J. Virol. 71:7289-7294.
40. van Kooyk, Y., and T. B. Geijtenbeek. 2003. DC-SIGN: escape mechanism for pathogens. Nat. Rev. Immunol. 3:697-709.
41. Waanders, G. A., A. N. Shakhov, W. Held, P. Karapetian, H. Acha-Orbea, and H. R. MacDonald. 1993. Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J. Exp. Med. 177:1359-1366.
42. Wilflingseder, D., Z. Banki, M. P. Dierich, and H. Stoiber. 2005. Mechanisms promoting dendritic cell-mediated transmission of HIV. Mol. Immunol. 42:229-237.
43. Yoshimoto, T., H. Nagase, H. Nakano, A. Matsuzawa, and H. Nariuchi. 1994. A Vβ8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice. Eur. J. Immunol. 24:1612-1619.
44. Zhang, Y., J. C. Rassa, E. M. deObaldia, L. Albritton, and S. R. Ross. 2003. Identification of the mouse mammary tumor virus envelope receptor-binding domain. J. Virol. 77:10468-10478.